The core of the approach, described by Zhiying Zeng, Liying Chang and colleagues under the supervision of Tao Liu, is a masking system built on genetic code expansion. The researchers engineered AAV capsid proteins to carry a non-canonical amino acid bearing a tetrazine group at a precisely chosen position on the viral surface. Tetrazines react rapidly and selectively with trans-cyclooctene, a pairing that has become one of the most reliable tools in bio-orthogonal chemistry. By attaching trans-cyclooctene-modified molecules to this tetrazine handle, the team could decorate the capsid at a single defined site rather than scattering modifications across the particle. This site-specificity matters because AAV infectivity depends on a small set of surface loops that engage cellular receptors; modifying the wrong residues would cripple the virus permanently rather than merely silencing it temporarily.

Two kinds of masking groups were tested. In one configuration, the researchers tethered a truncated fragment of the AAV receptor, the cellular protein that AAV must bind to enter cells, onto the capsid. This decoy fragment occupies the receptor-binding domains from the outside, physically blocking the real receptor on target cells from docking. In the other configuration, the team attached strands of polyethylene glycol, a hydrophilic polymer long used to shield biologics from immune surveillance. Both strategies achieved the same result: masked AAVs injected into mice showed essentially no transduction, their infectivity completely suppressed until the mask was deliberately removed. The PEGylated version carried an added benefit, since the polymer cloak also reduced recognition of the capsid by anti-AAV antibodies, a significant concern given that many patients carry pre-existing neutralizing antibodies against common AAV serotypes.

The unlock step relies on cleavable linkers, and the study demonstrates three distinct activation chemistries, each tailored to a different clinical scenario. The first is a protease-activated mask designed around matriptase-2, a serine protease whose expression is largely restricted to the liver. The masking group was connected to the capsid through a peptide linker carrying an matriptase-2 cleavage sequence. When the masked vector circulated through hepatic sinusoids, the liver enzyme clipped the linker, shed the mask, and restored the capsid’s ability to bind its receptor. In mice, systemic administration of these protease-activated particles produced gene expression concentrated in the liver, while a non-cleavable control linker kept the virus silent throughout the body. The result effectively converts liver tropism from a passive side effect of capsid biology into a programmable, switch-like property.

The second activation mode uses near-infrared light, offering something no endogenous trigger can: an external dial that an operator controls in space and time. Here the masking group was attached through a linker cleavable by near-infrared irradiation. After intravenous injection of the masked AAV9 vectors, the researchers shone near-infrared light on selected regions and observed transduction only where the beam had passed. In mice, this produced localized gene expression in the gastrocnemius muscle and, notably, in the brain, where light delivered through the skull activated vectors that had circulated inertly through the bloodstream. Because near-infrared light penetrates tissue more deeply than visible wavelengths, this scheme suggests a path toward optically demarcated gene delivery, in which a clinician traces the treatment zone with a light source and the vector follows that contour, leaving unilluminated tissue untouched.

The third chemistry exploits the inflammatory microenvironment itself. Diseased and injured tissues, from fibrotic liver to reperfused heart muscle, are rich in reactive oxygen species such as hydrogen peroxide, which healthy tissue maintains at far lower concentrations. The team designed a boronate-based linker that is stable in blood but cleaved by reactive oxygen species, so the mask falls off preferentially where oxidative stress marks the pathology. In a model of liver fibrosis, ROS-activated vectors showed controlled transduction consistent with the oxidative environment of the diseased organ. The strategy effectively lets the disease decrypt the vector: only tissue emitting the chemical signature of injury gains access to the therapeutic gene.

The most therapeutically compelling demonstration came in the heart. In a mouse model of myocardial ischaemia-reperfusion injury, the oxidative burst that accompanies restored blood flow to damaged tissue provided the activation signal. Intravenously administered ROS-activated masked AAV9 vectors unmasked preferentially in the injured myocardium and delivered a gene encoding VEGF-A165, a vascular endothelial growth factor isoform that promotes angiogenesis. Localized expression of the growth factor in the damaged heart improved cardiac function relative to controls, pointing toward a regenerative application in which a healing factor is produced exactly where the heart is remodeling, rather than systemically where it could promote unwanted vascular growth elsewhere.

Behind these demonstrations lies a substantial body of characterization work. The team quantified the pharmacokinetics of masked versus unmasked vectors, showing that PEGylation altered circulation behavior in measurable ways, and mapped biodistribution of vector genomes across organs to confirm that masking suppressed off-target accumulation of expression. Immunogenicity experiments showed that PEG-shielded capsids elicited lower anti-AAV antibody responses and resisted neutralization by human intravenous immunoglobulin better than unshielded particles, an encouraging signal for patients with pre-existing immunity. Structural data from the Protein Data Bank guided the choice of the capsid residue used for tetrazine incorporation, and the plasmids underlying the platform, including constructs for AAV-DJ, AAV9 and AAV8 capsids, have been deposited with Addgene, making the system available to other laboratories.

The conceptual lineage of this work runs through the prodrug field, in which pharmacologically inactive precursors are converted into active drugs by enzymes or chemistry specific to diseased tissue. Antibody probodies carrying tumor-protease-cleavable masks have already entered clinical trials, and earlier studies had produced protease-activatable AAVs and light-controlled viral transduction through other means. What distinguishes the new platform is the combination of genetically encoded, site-specific chemical handles with a modular family of cleavable linkers, allowing the same masked capsid chassis to be retargeted to liver, to an optical field, or to an oxidative injury zone simply by swapping the linker chemistry. That modularity, the authors suggest, makes the platform a general-purpose architecture rather than a single-purpose vector.

Cautions remain before such systems reach patients. The studies were conducted in mice, and the sensitivity, kinetics and completeness of unmasking in larger animals with different protease expression patterns, tissue optics and immune backgrounds will need to be established. Near-infrared activation requires a light source capable of reaching the target tissue, which constrains the approach to accessible sites or to applications where fiber-optic or transdermal illumination is feasible. ROS-triggered unmasking depends on the disease producing enough oxidative chemistry to cleave the linker within a useful window, and the specificity of that trigger across diverse pathologies will require careful validation. Even so, the demonstration that a single chemical masking principle can gate AAV infectivity behind three orthogonal keys, and that one of those keys can direct reparative gene expression to an injured heart, marks a meaningful advance in the quest to make gene therapy as much a matter of placement as of payload.

Subject of Research: Chemically masked adeno-associated viral vectors activated by disease-related signals for controlled gene delivery

Article Title: Controllable gene delivery via masked adeno-associated viral vectors

Article References: Zeng, Z., Chang, L., Wang, J., Liu, Y., Wang, X., Sun, Y., Zuo, Y., Hou, X., Wang, Y., Gu, Z., & Liu, T. (2026). Controllable gene delivery via masked adeno-associated viral vectors. Nature Materials. https://doi.org/10.1038/s41563-026-02724-1

Image Credits: AI Generated

DOI: 10.1038/s41563-026-02724-1

Keywords: adeno-associated virus, gene therapy, gene delivery, genetic code expansion, non-canonical amino acids, bio-orthogonal chemistry, matriptase-2, near-infrared light, reactive oxygen species, myocardial ischaemia-reperfusion, VEGF-A165, PEGylation

The research focuses on BaFe₂O₄, a barium ferrite that has received less attention than the better-known barium hexaferrite family. BaFe₂O₄ can crystallize in structures associated with different arrangements of barium, iron and oxygen ions, but the researchers produced a single-phase orthorhombic form. This type of ferrite is attractive because it combines chemical stability with magnetic and optical properties. Its reported Curie temperature is about 700 kelvin, while its coercivity can approach 4000 oersted, characteristics that have made ferrites useful in high-frequency electronics, microwave absorption and electromagnetic-interference shielding. At the nanoscale, however, particle aggregation can limit how effectively those properties are used. The study addresses that problem by embedding the ceramic particles in chitosan.

Chitosan is a cationic polysaccharide derived from chitin, the structural material found in sources such as crustacean shells. It can form films, biodegrade and interact with biological surfaces. Its positively charged amino groups can bind to negatively charged bacterial membranes, disturbing membrane integrity and affecting essential cellular processes. In the new composite, chitosan provides more than a supporting matrix: it supplies intrinsic antimicrobial activity while helping distribute the ferrite particles. The researchers prepared materials containing 20, 50 and 80 percent chitosan by weight, allowing them to examine how polymer loading changed the structure, optical response, heating behavior and antibacterial performance.

The ferrite was synthesized using a modified solution-combustion method. Barium nitrate and iron(III) nitrate were dissolved in water, while citric acid served as both a fuel and a complexing agent for the metal ions. After the solution was adjusted to approximately neutral pH and heated, evaporation produced a viscous gel that underwent spontaneous combustion. The resulting powder was then mixed with chitosan for about four hours in an agate mortar. Unlike conventional solid-state ferrite preparation, which can require prolonged high-temperature calcination, the combustion route produced a friable powder without an external furnace during the combustion step. The researchers characterized the products using X-ray diffraction, infrared spectroscopy, electron microscopy, elemental analysis, thermal analysis and ultraviolet-visible-near-infrared spectroscopy.

X-ray diffraction showed that the ferrite possessed an orthorhombic lattice with parameters of approximately 4.58, 11.04 and 8.08 angstroms for the a, b and c axes. The estimated crystallite sizes ranged from about 27 to 30 nanometers. Importantly, the diffraction pattern showed no detectable secondary peaks attributable to phases such as barium hexaferrite or hematite. After the ferrite was incorporated into chitosan, the characteristic ceramic reflections remained, indicating that the inorganic framework survived composite formation. A chitosan-related peak appeared near 12.6 degrees in 2θ, while modest changes in peak intensity and width were consistent with lower ferrite content or polymer-induced strain. Together, the results indicated that the process retained phase-pure BaFe₂O₄ within the polymer matrix.

Infrared measurements provided chemical evidence for both components. Bands associated with iron-oxygen and barium-oxygen vibrations remained visible at low wavenumbers, while the composite displayed chitosan signatures linked to hydroxyl, amino, amide, glycosidic and carbon-oxygen groups. The researchers interpreted the interaction between the two materials as being dominated by hydrogen bonding and electrostatic forces rather than the formation of new covalent bonds. Electron microscopy reinforced that interpretation at the structural level. Pure ferrite appeared as irregular, agglomerated particles with rough and porous surfaces, whereas the composite had a smoother, more homogeneous and partly flaky morphology. Individual nanoparticles were difficult to distinguish in the polymer-rich material, suggesting that chitosan reduced direct particle-to-particle contact and improved dispersion. Energy-dispersive X-ray analysis detected barium, iron and oxygen in the ceramic and a stronger carbon signal after chitosan incorporation.

The polymer altered the material’s optical behavior in a way that favored photothermal heating. Pure BaFe₂O₄ absorbed broadly across the visible spectrum and into the near-infrared, with an estimated optical band gap of about 2.27 electronvolts. Tauc analysis gave progressively smaller values as chitosan content increased: approximately 2.09 electronvolts for the 20 percent formulation, 2.01 electronvolts for the 50 percent formulation and 1.99 electronvolts for the 80 percent formulation. The researchers caution that the precise electronic mechanism cannot be established without additional techniques such as X-ray photoelectron spectroscopy or photoluminescence measurements. They propose that interfaces between ferrite and polymer may introduce localized energy states or improve the distribution of absorbing particles. Although chitosan itself has little visible or near-infrared absorption, the composite absorbed more strongly across both regions as its chitosan fraction increased, an effect attributed to improved dispersion and interfacial interactions.

Under natural sunlight, aqueous dispersions containing 1 milligram of material per milliliter warmed from room temperature toward a steady state. Pure barium ferrite reached approximately 53.0 °C, while pure chitosan reached about 54.9 °C. The composite temperatures increased with polymer loading: about 56.1 °C for 20 percent chitosan, 60.2 °C for 50 percent and 62.3 °C for 80 percent. The corresponding calculated photothermal conversion efficiencies were approximately 73.5, 76.8, 78.5, 80.2 and 82.3 percent for ferrite, chitosan and the three composites, respectively. These values describe the experimental setup and calculation method, including the assumed heat capacity of the aqueous dispersion, rather than a universal performance rating. The apparent efficiency declined at higher temperatures as heat escaped to the surroundings and the samples approached thermal equilibrium.

The biological tests compared the materials against Gram-positive Streptococcus pyogenes and Gram-negative Acinetobacter baumannii, using standardized cultures and viable colony counts. Samples were tested both in darkness and after irradiation with an 808-nanometer near-infrared laser at 2 watts per square centimeter for five minutes. Without irradiation, antibacterial activity increased with chitosan content, consistent with membrane disruption by the polymer’s positively charged amino groups. The composites produced more than 90 percent inhibition for both bacterial strains under the reported dark conditions. With near-infrared exposure, the 80 percent chitosan composite heated from about 25 to 42 °C in five minutes and achieved approximately 100 percent inhibition in the colony-counting assay. The likely explanation is a two-part mechanism: chitosan first weakens bacterial membranes, while ferrite-mediated heating adds rapid thermal damage to membranes and intracellular molecules.

That combination is the central promise of the material, but it also defines the limits of the current evidence. The experiments demonstrate activity against two laboratory strains in controlled suspensions; they do not establish safety, durability, performance on complex surfaces, effectiveness against diverse clinical isolates or suitability for use in people. The study also does not show that bacterial resistance is impossible, even though a physical photothermal mechanism may impose different selective pressures from conventional antibiotics. Further work would need to examine repeated irradiation cycles, material release, long-term stability, toxicity to human and environmental cells, and performance in realistic fluids or surface coatings. The authors nevertheless identify the BaFe₂O₄–chitosan system as a low-cost route to antibiotic-free disinfection. By combining a stable, light-absorbing ferrite with a biodegradable antimicrobial polymer, the composite offers a tunable materials strategy in which light can switch additional antibacterial power on when and where it is needed.

Thermal analysis adds an important distinction between the organic and inorganic components. The chitosan portion underwent its characteristic degradation mainly between 200 and 400 °C, whereas the ferrite framework remained comparatively stable. About 65% of the sample mass remained at 900 °C, consistent with a substantial inorganic residue and indicating that composite heating does not simply destroy the ceramic phase. This result is relevant to processing and storage, but it should not be interpreted as evidence that the material is suitable for direct contact with living tissue at such temperatures. In practical antimicrobial operation, the intended temperatures are far lower and the relevant questions would instead involve repeated heating and cooling, moisture exposure and mechanical integrity.

The preparation strategy also affects how the reported properties should be interpreted. Solution combustion can generate a highly porous, friable powder rapidly, while subsequent four-hour mortar mixing is a relatively simple way to vary polymer loading without introducing a separate high-temperature consolidation step. The resulting material is therefore best understood as a particulate nanocomposite rather than a fully engineered coating or membrane. For deployment, researchers would need to control thickness, surface roughness, ferrite retention and optical penetration. Those factors could change both the temperature reached under illumination and the accessibility of chitosan’s charged groups to microorganisms. The study’s microscopy and elemental mapping support incorporation and dispersion, but they do not by themselves establish uniformity throughout a large-area coating.

BaFe₂O₄ also gives the composite a possible magnetic handle, although the reported work primarily evaluates structure, optical absorption, heating and antibacterial activity rather than demonstrating magnetic separation or field-guided placement. If that functionality is confirmed in later studies, it could help recover particles from treated liquids or position them on a surface; recovery would be especially important when assessing environmental release. Likewise, the antibacterial results show an outcome under defined irradiation and culture conditions, not the relative contribution of heat, membrane contact, and any light-induced chemical effects. Experiments using temperature-matched dark controls, ferrite-only and chitosan-only comparisons, reactive-species probes, and repeated treatment cycles would help separate these mechanisms and determine whether the composite retains activity after use.

Subject of Research: Barium ferrite–chitosan nanocomposites for photothermal heating and antibacterial disinfection

Article Title: Barium ferrite-chitosan nanocomposite for efficient photothermal heating and broad-spectrum antibacterial activity

Article References: Shahina, S. R., Mary, J., & Vidya, S. (2026). Barium ferrite-chitosan nanocomposite for efficient photothermal heating and broad-spectrum antibacterial activity. Journal of Materials Science: Polymers, 1(1), Article 25. https://doi.org/10.1007/s44493-026-00026-1

Image Credits: AI Generated

DOI: 10.1007/s44493-026-00026-1

Keywords: barium ferrite, chitosan, nanocomposites, photothermal heating, near-infrared light, antibacterial materials, nanomaterials, light-activated disinfection, Barium, ferrite-chitosan, nanocomposite, efficient